3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Glioblastoma
2
Neoplasms
1
Gliosarcoma
1
Brain Neoplasms
1
Interventions
Temozolomide
8
Radiotherapy
6
Procarbazine
4
Radiation
3
Lomustine
3
Carmustine
3
Dihematoporphyrin Ether
2
sargramostim
1
rindopepimut
1
depatuxizumab mafodotin
1
Vincristine
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Photons
1
O(6)-benzylguanine
1
Neoadjuvant Therapy
1
Methylphenidate
1
Magnetic Resonance Spectroscopy
1
Leflunomide
1
Isotretinoin
1
Immunoglobulin G
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Fentanyl
1
Donepezil
1
Disulfides
1
DNA Methylation
1
Chemotherapy, Adjuvant
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Gliosarcoma
×
ABT-414
×
Clear all
NCT02573324
2023-05-11
Intellance1
AbbVie
Phase 3
Completed
691 enrolled
28 charts